103 related articles for article (PubMed ID: 7992223)
1. [The basic antihypertensive drugs for the long-term secondary prevention of cardiovascular diseases (the working group of the multicenter study Captopril and the Quality of Life)].
Metelitsa VI; Ostrovskaia TP; Duda SG; Filatova NP; Vygodin VA; Mukhamedzhanova GF
Ter Arkh; 1994; 66(9):78-82. PubMed ID: 7992223
[No Abstract] [Full Text] [Related]
2. [The effect of long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents on the quality of life in patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working group of the Multicenter Captopril and the Quality of Life Study].
Metelitsa VI; Duda SG; Ostrovskaia TP; Filatova NP; Mukhamedzhanova GF; Vygodin VA; Siegrist J; Broer M
Ter Arkh; 1995; 67(9):45-50. PubMed ID: 7495042
[TBL] [Abstract][Full Text] [Related]
3. [The Multicenter Captopril and the Quality of Life Study: the effect of antihypertensive agents from the basic groups on the quality of life of patients in different populations. The working group of the Multicenter Captopril and the Quality of Life Study].
Metelitsa VI; Duda SG; Ostrovskaia TP; Filatova NP; Mukhamedzhanova GF; Vygodin VA; Broer M; Siegrist I
Ter Arkh; 1996; 68(4):29-36. PubMed ID: 9324785
[TBL] [Abstract][Full Text] [Related]
4. [The long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents of patients with mild and moderate arterial hypertension. The Multicenter Captopril and the Quality of Life Study. The working group of the Multicenter Captopril and the Quality of Life Study].
Metelitsa VI; Ostrovskaia TP; Duda SG; Filatova NP; Vygodin VA
Ter Arkh; 1995; 67(6):15-20. PubMed ID: 7667771
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive therapy and quality of life.
Rakel RE
Am Fam Physician; 1987 Mar; 35(3):221-6. PubMed ID: 3548293
[TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular risk profile and anti-hypertensive treatment].
Olsen MH; Sehestedt T; Prescott E
Ugeskr Laeger; 2009 Jun; 171(24):2008-11. PubMed ID: 19523363
[TBL] [Abstract][Full Text] [Related]
7. [Long-term efficacy of captopril in the treatment of moderate/intensive arterial hypertension resistant to 3 antihypertensive drugs].
Oliván J; Miranda MJ; Chozas J; Gras BX; Garrido M
Med Clin (Barc); 1985 Nov; 85(14):571-4. PubMed ID: 3908849
[No Abstract] [Full Text] [Related]
8. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
Yodfat Y; Bar-On D; Amir M; Cristal N
J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive treatment and homocysteine concentrations.
Westphal S; Rading A; Luley C; Dierkes J
Metabolism; 2003 Mar; 52(3):261-3. PubMed ID: 12647260
[TBL] [Abstract][Full Text] [Related]
10. Taking risks: primary prevention of cardiovascular events.
Vallance P
N Z Med J; 2001 May; 114(1132):223-4. PubMed ID: 11453356
[No Abstract] [Full Text] [Related]
11. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
[TBL] [Abstract][Full Text] [Related]
12. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension.
Ogilvie RI; Burgess ED; Cusson JR; Feldman RD; Leiter LA; Myers MG
CMAJ; 1993 Sep; 149(5):575-84. PubMed ID: 8364814
[No Abstract] [Full Text] [Related]
13. Effects of different antihypertensive agents on the overall cardiovascular risk profile.
Crepaldi G; Pessina AC; Rahn KH
J Hypertens Suppl; 1993 Dec; 11(6):S37-9. PubMed ID: 8169382
[No Abstract] [Full Text] [Related]
14. [Prevention in cardiovascular pathology].
Chamontin B; Amar J
Therapie; 2001; 56(2):119-24. PubMed ID: 11471362
[TBL] [Abstract][Full Text] [Related]
15. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
Amir M; Cristal N; Bar-On D; Loidl A
Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
Thulin T; Lehtonen A; Dahlöf C; Nilsson-Ehle P; Engqvist L; Lagerstedt C; Berglund E
Int J Clin Pharmacol Ther; 1999 Jan; 37(1):28-33. PubMed ID: 10027480
[TBL] [Abstract][Full Text] [Related]
17. [Particularities of hypertension in diabetic patient].
Valensi P
Rev Prat; 2004 Mar; 54(6):633-6. PubMed ID: 15222614
[TBL] [Abstract][Full Text] [Related]
18. [Use captopril and estradiol-medroxyprogesterone in premenopausal hypertensive patients].
Zayas Jaime FJ; Ortega Clavero H; Baños Baños A; Lazo Javalera F
Ginecol Obstet Mex; 2000 Dec; 68():469-75. PubMed ID: 11195960
[TBL] [Abstract][Full Text] [Related]
19. Quality of life of patients with mild hypertension treated with captopril: a randomized double-blind placebo-controlled clinical trial.
Hu Y; Zhu J
Chin Med J (Engl); 1999 Apr; 112(4):302-7. PubMed ID: 11593526
[TBL] [Abstract][Full Text] [Related]
20. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile].
Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
Eksp Klin Farmakol; 2001; 64(2):45-50. PubMed ID: 11548448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
